NP37122 ENT, Ophthalmology & Skin Medicines/Medical Devices
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)contractFind a Tender ↗Ref ocds-h6vhtk-0371cc32014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
46
Lots
2
2 awarded
Published
30 Sept 2022
Other contracts from The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)· 10
Most recent notices published by the same contracting authority.
| Title | Type | Value | Published |
|---|---|---|---|
| Information Technology Service Management | contract | — | 08 May 2026 |
| Patient Carer Online Feedback Service | contract | — | 08 May 2026 |
| NP49425 Generic and Biosimilar Transition Medicines | contract | — | 30 Mar 2026 |
| NP884925 Adobe Licence | contract | — | 27 Mar 2026 |
| Automated AST & Bacteria Testing | contract | — | 27 Mar 2026 |
| Sampling & Measuring Products | contract | — | 25 Mar 2026 |
| NP90726l Tildrakizumab (Ilumetri®) | contract | — | 17 Mar 2026 |
| Ophthalmology Equipment | contract | £8.0m | 11 Mar 2026 |
| Insulin Infusion Pumps, Continuous Glucose Monitoring Systems and Associated Consumables | contract | £100.0m | 11 Mar 2026 |
| Single Use Podiatry Instruments | contract | £2.0m | 11 Mar 2026 |
Other contracts awarded to Zentiva Pharma UK Ltd· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 | contract | — | 09 Jun 2026 |
| NHS National Generics Pharmaceuticals - Supply Chain Resilience | contract | — | 01 May 2026 |
| NHS National Branded Interim - 1 June 2026 | contract | — | 16 Apr 2026 |
| NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide | contract | — | 26 Mar 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 26 Feb 2026 |
| NHS National Framework for Transition Products (Nintedanib and Dalbavancin) | contract | — | 25 Feb 2026 |
| Transitional Drugs 6 | contract | — | 04 Feb 2026 |
| NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin | contract | — | 30 Jan 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 14 Jan 2026 |
| Generic, Branded Generic & Proprietary Medicinal Products - Group 17 | contract | — | 12 Jan 2026 |